MEDICLUS appears in FDA device records as the applicant for dental materials filed under the 510(k) pathway. The supplied collection snapshot, retrieved 20 November 2026, links one record to the company: Ezi-Crown, submission K263004, product code EBG, decided 3 November 2026 with decision code SESE, described by FDA as substantially equivalent. That single linked record is a snapshot of the supplied filings, not a statement of total portfolio size, sales or safety performance. Company product descriptions come from MEDICLUS's own website pages, which describe Ezi-Crown as a light-cured temporary crown and bridge resin. [1][2][5]

The Ezi-Crown filing and its scope

FDA's record for K263004 lists MEDICLUS as applicant, with a Cheongju-Si address in the Republic of Korea, and names Ezi-Crown as the device. The submission was received 28 August 2026 and decided 3 November 2026 as a Traditional clearance with a Summary, under product code EBG and the dental advisory committee. The openFDA fields associate the product code with the device name Crown And Bridge, Temporary, Resin, regulation number 872.3770 and Class II. [1]

MEDICLUS's product page describes Ezi-Crown as a light-cured temporary crown and bridge resin used to make temporary inlays, onlays, crowns and bridges, and as provisional restorations placed during indirect and prosthodontic treatment. The same page lists stated handling features, including ready-to-use presentation, non-sticky handling, no odor, heat-free polymerization, less dust than conventional materials, light cure in 20 seconds and no mixing tips. These are the publisher's product claims, not independently verified performance data. [2][3]

Other documented filings

Two further FDA clearance letters in the public documents name Mediclus Co., Ltd. as the submitter. K253167, dated 12 January 2026, covers Any-Paste under regulation 21 CFR 872.3820, root canal filling resin, Class II, product code KIF. K261728, dated 21 July 2026, covers One-Fil LC under 21 CFR 872.3250, calcium hydroxide cavity liner, Class II, product code EJK. Both letters list a Cheongju-si address and a regulatory contact. [6][7]

These letters are separate from the linked portfolio record and are not counted in the collection snapshot. They show the applicant name appearing across endodontic and restorative device categories as well as prosthodontics, but they do not establish total company portfolio size or commercial status of any product. [6][7]

Product line context

MEDICLUS's prosthodontics catalog page lists ten products, including Ezi-Crown alongside cements, a gingival retraction paste, a core build-up composite and a temporary filling material. Some catalog entries carry FDA and CE labels on the company's own page. The catalog is a company-published listing; it is not an FDA record and does not by itself confirm clearance status for each item. [5]

A downloadable Ezi-Crown document shows clinical case photography captioned with steps such as applying a separating agent, applying Ezi-Crown, curing for 20 seconds, removal and trimming, and fixing with temporary cement. The document identifies cases by clinician name. It is company-published material and does not report measured outcomes. [4]

Identity and limits of the record

The documented legal applicant is MEDICLUS, with Mediclus Co., Ltd. used in FDA correspondence. Filing addresses in Cheongju-si and Seoul appear in company and FDA documents; these are correspondence and office addresses, not a verified headquarters designation. No parent company, brand ownership or corporate structure is established in the public documents. [1][3][6]

The collection snapshot records one linked 510(k) record with one SESE decision, and the sample contains that same single record. Recall sample data is empty. These counts describe the supplied filings as of the retrieval date and should not be read as total clearances, sales figures or safety performance. [1]